Stock Screener App

Frei -

Installieren

3.46

2.54% -0.09

after-market

Handel nachbörslich: 3.46

Rocket Pharmaceuticals Inc (RCKT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Rocket Pharmaceuticals Inc-Aktie (RCKT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	15.86% 43.96	52.25	71.15	64.39	69.42
Interest Income/Expense	0.00% 0.473	0.473	0.473	0.472	0.471
Operating Income/Loss	15.86% -43.96	-52.25	-71.15	-64.39	-69.42
Income/Loss From Continuing Operations Before Tax	15.49% -42.54	-50.33	-68.92	-61.33	-66.72
Income/Loss From Continuing Operations After Tax	15.49% -42.54	-50.33	-68.92	-61.33	-66.72
Net Income/Loss	15.49% -42.54	-50.33	-68.92	-61.33	-66.72
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.80% 0.2236	111.57	111.02	110.09	94.16
Diluted Average Shares	99.80% 0.2236	111.57	111.02	110.09	94.16
Basic Earnings Per Share	15.56% -0.38	-0.45	-0.62	-0.56	-0.71
Diluted Earnings Per Share	15.56% -0.38	-0.45	-0.62	-0.56	-0.71
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

MRNA

$48.77

0.87%

ROIV

$27.88

1.59%

RPRX

$47.32

2.57%

BNTX

$91.28

0.11%

ONC

$302.49

2.67%

INSM

$163.81

0.85%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters